$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Antisense modulation of BCL-X expression 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07H-021/02
  • C07H-021/04
  • C12N-015/85
  • C12N-015/86
  • C12Q-001/68
  • A61K-031/70
출원번호 US-0167921 (1998-10-07)
발명자 / 주소
  • Bennett C. Frank
  • Dean Nicholas M.
  • Monia Brett P.
  • Nickoloff Brian J.
  • Zhang QingQing
출원인 / 주소
  • Isis Pharmaceuticals Inc.
대리인 / 주소
    Law Offices of Jane Massey Licata
인용정보 피인용 횟수 : 172  인용 특허 : 7

초록

Compositions and methods are provided for modulating the expression of bcl-x. Antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding bcl-x are preferred. Methods of using these compounds for modulation of bcl-x expression and for treatment of diseases associ

대표청구항

[ What is claimed is:] [1.] An antisense compound 8 to 30 nucleotides in length targeted to a nucleic acid molecule encoding a human bcl-x, wherein said antisense compound modulates the expression of human bcl-x, and wherein said antisense compound is an antisense oligonucleotide which comprises at

이 특허에 인용된 특허 (7)

  1. Gibbons Gary H. ; Pollman Matthew J., Apoptotic regression of intimal vascular lesions.
  2. Green Douglas R. (San Diego CA) Cotter Thomas G. (Co. Kildare IEX), Enhancement of adoptosis using antisense oligonucleotides.
  3. Metelev Valeri (Shrewsbury MA) Agrawal Sudhir (Shrewsbury MA), Hybrid oligonucleotide phosphorothioates.
  4. Agrawal Sudhir, Oligonucleotides having modified CpG dinucleosides.
  5. Summerton, James E.; Weller, Dwight D., Uncharged morpholino-based polymers having achiral intersubunit linkages.
  6. Thompson Craig B. (Chicago IL) Boise Lawrence H. (Chicago IL) Nunez Gabriel (Ann Arbor MI), Vertebrate apoptosis gene: compositions and methods.
  7. Thompson Craig B. ; Boise Lawrence H. ; Nunez Gabriel, Vertebrate apoptosis gene: compositions and methods.

이 특허를 인용한 특허 (172)

  1. Prakash, Thazha P.; Baker, Brenda F.; Eldrup, Anne B.; Manoharan, Muthiah; Bhat, Balkrishen; Griffey, Richard; Swayze, Eric E.; Crooke, Stanley T., 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations.
  2. Geary, Richard S.; Yu, Zhengrong; Wedel, Mark K.; Tribble, Diane, Administering antisense oligonucleotides complementary to human apolipoprotein B.
  3. Iversen, Patrick L.; Weller, Dwight D.; Timmins, Alan P., Antisense composition and method for treating muscle atrophy.
  4. Iversen, Patrick L.; Weller, Dwight D.; Timmins, Alan P., Antisense composition and method for treating muscle atrophy.
  5. Iversen, Patrick L.; Weller, Dwight D.; Timmins, Alan P., Antisense composition and method for treating muscle atrophy.
  6. Hastings, Michelle L.; Isacson, Ole; Korecka-Roet, Joanna A., Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease.
  7. Crooke, Rosanne M.; Graham, Mark J., Antisense modulation of apolipoprotein B expression.
  8. Crooke, Rosanne M.; Graham, Mark J., Antisense modulation of apolipoprotein B expression.
  9. Crooke, Rosanne M.; Graham, Mark J., Antisense modulation of apolipoprotein B expression.
  10. Crooke,Rosanne M.; Graham,Mark J., Antisense modulation of apolipoprotein B expression.
  11. Crooke,Roseanne M.; Graham,Mark; Freier,Susan M., Antisense modulation of apolipoprotein B expression.
  12. Crooke, Rosanne M.; Graham, Mark J.; Freier, Susan M., Antisense modulation of apolipoprotein B-expression.
  13. Crooke, Rosanne M.; Graham, Mark J.; Freier, Susan M., Antisense modulation of apolipoprotein B-expression.
  14. Bennett,C. Frank; Dean,Nicholas M.; Monia,Brett P.; Nickoloff,Brian J.; Zhang,Vivian Q., Antisense modulation of bcl-x expression.
  15. Riley, Timothy A.; Brown, Bob D.; Arnold, Lyle J., Antisense oligonucleotides with increased RNase sensitivity.
  16. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen; Zellweger, Tobias, Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides.
  17. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen; Zellweger, Tobias, Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides.
  18. Gleave, Martin; Rennie, Paul S.; Miyake, Hikeaki; Nelson, Colleen; Zellweger, Tobias, Chemo-and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides.
  19. Crooke, Stanley T., Chimeric oligomeric compounds and their use in gene modulation.
  20. Bennett, C. Frank; Dean, Nicholas M.; Kole, Ryszard M.; Kopczynski, Casey C., Chimeric oligomeric compounds for modulation of splicing.
  21. Bennett, C. Frank; Dean, Nicholas M.; Kole, Ryszard; Kopczynski, Casey C., Chimeric oligomeric compounds for modulation of splicing.
  22. Gleave, Martin E.; Cormack, Scott D., Clusterin antisense therapy for treatment of cancer.
  23. Gleave, Martin E.; Cormack, Scott D., Clusterin antisense therapy for treatment of cancer.
  24. Baker, Brenda F.; Krainer, Adrian R.; Hua, Yimin, Compositions and methods for modulation of SMN2 splicing.
  25. Baker, Brenda F.; Krainer, Adrian R.; Hua, Yimin, Compositions and methods for modulation of SMN2 splicing.
  26. Bennett, C. Frank; Hung, Gene; Rigo, Frank, Compositions and methods for modulation of SMN2 splicing in a subject.
  27. Bennett, C. Frank; Hung, Gene; Rigo, Frank; Krainer, Adrian R.; Hua, Yimin; Passini, Marco A.; Shihabuddin, Lamya; Cheng, Seng H.; Klinger, Katherine W., Compositions and methods for modulation of SMN2 splicing in a subject.
  28. Bennett, C. Frank; Hung, Gene; Rigo, Frank; Krainer, Adrian R.; Hua, Yimin; Passini, Marco A.; Shihabuddin, Lamya; Cheng, Seng H.; Klinger, Katherine W., Compositions and methods for modulation of SMN2 splicing in a subject.
  29. Sacks, Frank M.; Tribble, Diane, Compositions and methods of targeting apolipoprotein B for the reduction of apolipoprotein C-III.
  30. Allerson, Charles; Bhat, Balkrishen; Eldrup, Anne B.; Manoharan, Muthiah; Griffey, Richard H.; Baker, Brenda F.; Swayze, Eric E., Compositions comprising alternating 2′-modified nucleosides for use in gene modulation.
  31. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression ApoB.
  32. Bennett, C. Frank, Compounds and methods for modulating protein expression.
  33. Bennett, C. Frank, Compounds and methods for modulating protein expression.
  34. Bennett, C. Frank; McKay, Robert; Monia, Brett P.; Baker, Brenda F.; Sioufi, Namir, Conjugates for use in hepatocyte free uptake assays.
  35. Baker, Brenda F.; Kraynack, Bryan A., Double stranded constructs comprising one or more short strands hybridized to a longer strand.
  36. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen, Functional and hyperfunctional siRNA.
  37. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen, Functional and hyperfunctional siRNA.
  38. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen; Read, Steven, Functional and hyperfunctional siRNA.
  39. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen; Read, Steven, Functional and hyperfunctional siRNA directed against Bcl-2.
  40. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen; Read, Steven, Functional and hyperfunctional siRNA directed against Bcl-2.
  41. van Ommen, Garrit-Jan B.; van Deutekom, Judith C. T.; den Dunnen, Johannes T., Induction of exon skipping in eukaryotic cells.
  42. Aartsma-Rus, Annemieke; Van Deutekom, Judith Christina T.; Van Ommen, Garrit-Jan Boudewijn, Means and method for inducing exon-skipping.
  43. De Kimpe, Josephus Johannes; Platenburg, Gerard Johannes; Van Deutekom, Judith Christina Theodora; Aartsma-Rus, Annemieke; Van Ommen, Garrit-Jan Boudewijn, Means and methods for counteracting muscle disorders.
  44. Platenburg, Gerard Johannes; de Kimpe, Josephus Johannes; van Deutekom, Judith Christina Theodora; van Ommen, Garrit-Jan Boudewijn; Aartsma-Rus, Annemieke, Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means.
  45. Platenburg, Gerard Johannes; de Kimpe, Josephus Johannes; van Deutekom, Judith Christina Theodora; van Ommen, Garrit-Jan Boudewijn; Aartsma-Rus, Annemieke, Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means.
  46. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, Methods and compositions for selecting siRNA of improved functionality.
  47. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, Methods and compositions for selecting siRNA of improved functionality.
  48. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, Methods and compositions for selecting siRNA of improved functionality.
  49. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, Methods and compositions for selecting siRNA of improved functionality.
  50. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, Methods and compositions for selecting siRNA of improved functionality.
  51. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, Methods and compositions for selecting siRNA of improved functionality.
  52. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, Methods and compositions for selecting siRNA of improved functionality.
  53. van Deutekom, Judith Christina Theodora, Methods and means for efficient skipping of at least one of the exons 51-53, 55, 57 and 59 of the human duchenne muscular dystrophy gene.
  54. De Kimpe, Josephus Johannes; Platenburg, Gerardus Johannes; Van Deutekom, Judith Christina Theodora; Aartsma-Rus, Annemieke; Van Ommen, Garrit-Jan Boudewijn, Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA.
  55. De Kimpe, Josephus Johannes; Rus, Adriana Marie; Platenburg, Gerard Johannes; Van Deutekom, Judith Christina Theodora; Van Ommen, Garrit-Jan Boudewijn, Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA.
  56. de Kimpe, Josephus Johannes; Platenburg, Gerardus Johannes, Methods and means for treating DNA repeat instability associated genetic disorders.
  57. Van Deutekom, Judith Christina Theodora, Modulation of exon recognition in pre-mRNA by interfering RNA structure.
  58. Van Deutekom, Judith Christina Theodora, Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure.
  59. Van Deutekom, Judith Christina Theodora; van Ommen, Garrit-Jan B.; Aartsma-Rus, Annemieke; den Dunnen, Johannes Theodorus, Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure.
  60. van Deutekom, Judith Christina Theodora, Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure.
  61. van Ommen, Garrit-Jan Boudewijn; van Deutekom, Judith Christina Theodora; den Dunnen, Johannes Theodorus; Aartsma-Rus, Annemieke, Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure.
  62. Dobie, Kenneth W; Jain, Ravi, Modulation of growth hormone receptor expression and insulin-like growth factor expression.
  63. Dobie, Kenneth; Jain, Ravi, Modulation of growth hormone receptor expression and insulin-like growth factor expression.
  64. Tachas, George, Modulation of growth hormone receptor expression and insulin-like growth factor expression.
  65. Tachas, George, Modulation of growth hormone receptor expression and insulin-like growth factor expression.
  66. Tachas, George; Dobie, Kenneth W; Jain, Ravi; Belyea, Christopher I; Heffernan, Mark A, Modulation of growth hormone receptor expression and insulin-like growth factor expression.
  67. Tachas, George; Dobie, Kenneth; Jain, Ravi; Belyea, Christopher; Heffernan, Mark, Modulation of growth hormone receptor expression and insulin-like growth factor expression.
  68. Tachas, George; Dobie, Kenneth; Jain, Ravi; Belyea, Christopher; Heffernan, Mark, Modulation of growth hormone receptor expression and insulin-like growth factor expression.
  69. Kandimalla,Ekambar R.; Zhao,Qiuyan; Yu,Dong; Agrawal,Sudhir, Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes.
  70. Van Ommen, Garrit-Jan Boudewijn; Aartsma-Rus, Annemieke; Van Deutekom, Judith Christina Theodora; De Kimpe, Josephus Johannes; Verbeek, Joseph Stephan; Ylmaz-Elis, Aliye Seda, Molecule for treating an inflammatory disorder.
  71. Heemskerk, Johannes Antonius; Van Deutekom, Judith Christina Theodora; Van Kuik-Romeijn, Petra; Platenburg, Gerard Johannes, Molecules for targeting compounds to various selected organs or tissues.
  72. Kuik-Romeijn, Petra Van; Platenburg, Gerard Johannes, Molecules for targeting compounds to various selected organs, tissues or tumor cells.
  73. Dickson, John George; Kang, Jagjeet Kaur, Oligomers.
  74. Brown, Bob D.; Riley, Timothy A., Oligonucleotide probes and primers comprising universal bases for diagnostic purposes.
  75. Crooke, Stanley T., Oligoribonucleotides and ribonucleases for cleaving RNA.
  76. Bhat, Balkrishen; Swayze, Eric E.; Prakash, Thazha P.; Allerson, Charles; Dande, Prasad; Griffey, Richard H., Positionally modified siRNA constructs.
  77. de Visser, Peter Christian; van Deutekom, Judith Christina Theodora, RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy.
  78. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, RNAi targeting CNTD2.
  79. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, RNAi targeting SEC61G.
  80. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, RNAi targeting ZNF205.
  81. Crooke, Rosanne M.; Graham, Mark J.; Mah, Steven, SNPs of apolipoprotein B and modulation of their expression.
  82. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Short antisense compounds with gapmer configuration.
  83. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen; Read, Steven, SiRNA targeting KRAS.
  84. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting apolipoprotein B (APOB).
  85. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting beta secretase (BACE).
  86. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting catenin, beta-1 (CTNNB1).
  87. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting connective tissue growth factor (CTGF).
  88. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B).
  89. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting diacylglycerol O-acyltransferase homolog 2 (DGAT2).
  90. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting fructose-1, 6-bisphosphatase 1 (FBP1).
  91. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting glucagon receptor (GCGR).
  92. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting histamine receptor H1.
  93. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting myeloid differentiation primary response gene (88) (MYD88).
  94. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting myeloid differentiation primary response gene (88) (MYD88).
  95. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting proto-oncogene MET.
  96. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, SiRNA targeting ras-related nuclear protein RAN.
  97. Iversen, Patrick L.; Hudziak, Robert, Splice-region antisense composition and method.
  98. Iversen, Patrick L.; Hudziak, Robert, Splice-region antisense composition and method.
  99. Iversen, Patrick L.; Hudziak, Robert, Splice-region antisense composition and method.
  100. Iversen, Patrick L.; Hudziak, Robert; Weller, Dwight D., Splice-region antisense composition and method.
  101. Kolb, Hartmuth C.; Walsh, Joseph C.; Chen, Kai; Gangadharmath, Umesh B.; Chen, Gang; Mocharla, Vani P.; Kasi, Dhanalakshmi; Scott, Peter J. H.; Liang, Qianwa, Substrate based PET imaging agents.
  102. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen, TRPM-2 antisense therapy.
  103. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen, TRPM-2 antisense therapy.
  104. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen, TRPM-2 antisense therapy.
  105. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen, TRPM-2 antisense therapy.
  106. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen, TRPM-2 antisense therapy.
  107. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen, TRPM-2 antisense therapy.
  108. Gleave,Martin; Rennie,Paul S.; Miyake,Hideaki; Nelson,Colleen, TRPM-2 antisense therapy.
  109. Gleave, Martin; Rennie, Paul S.; Miyake, Hideaki; Nelson, Colleen; Monia, Brett P., TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications.
  110. 't Hoen, Peter Abraham Christiaan; Sterrenburg, Petronella Johanna Elisabeth; den Dunnen, Johannes Theodorus; van Ommen, Garrit Jan Boudewijn, Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene.
  111. Gleave, Martin, Treatment of cancer by inhibition of IGFBP's and clusterin.
  112. Gleave, Martin E., Treatment of cancer by inhibition of IGFBPs and clusterin.
  113. Gleave, Martin E., Treatment of cancer by inhibition of IGFBPs and clusterin.
  114. Gleave, Martin E., Treatment of cancer by inhibition of IGFBPs and clusterin.
  115. Gleave, Martin E., Treatment of cancer by inhibition of IGFBPs and clusterin.
  116. De Kimpe, Josephus Johannes; Platenburg, Gerard Johannes; Wansink, Derick Gert, Treatment of genetic disorders associated with DNA repeat instability.
  117. Gleave,Martin; Jansen,Burkhard, Treatment of melanoma by reduction in clusterin levels.
  118. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen; Read, Steven, siRNA targeting BCL2L1.
  119. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen; Read, Steven, siRNA targeting KRAS.
  120. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen; Read, Steven, siRNA targeting KRAS.
  121. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1).
  122. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1).
  123. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1).
  124. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting TIE-2.
  125. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting TIE-2.
  126. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting TNFα.
  127. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting amyloid beta (A4) precursor protein (APP).
  128. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting amyloid beta (A4) precursor protein (APP).
  129. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting apolipoprotein B (APOB).
  130. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting beta secretase (BACE).
  131. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting cAMP-specific phosphodiesterase 4D.
  132. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting casitas B cell lymphoma-B (CBL-B).
  133. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting coatomer protein complex, subunit beta 2 (COPB2).
  134. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting complement component 3 (C3).
  135. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen; Read, Steven, siRNA targeting complement factor B.
  136. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting connective tissue growth factor (CTGF).
  137. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting connective tissue growth factor (CTGF).
  138. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting connective tissue growth factor (CTGF).
  139. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting cyclin dependent kinase 11 (CDK11).
  140. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting cyclin-dependent kinase 4 (CDK4).
  141. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B).
  142. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B).
  143. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting diacylglycerol O-acyltransferase homolog 2 (DGAT2).
  144. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting gremlin.
  145. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting gremlin.
  146. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting histamine receptor H1.
  147. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting histamine receptor H1.
  148. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting hypoxia-inducible factor 1.
  149. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4).
  150. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4).
  151. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting interleukin-1 receptor-associated kinase 4(IRAK4).
  152. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting kinase insert domain receptor (KDR).
  153. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting kinase insert domain receptor (KDR).
  154. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen; Read, Steven, siRNA targeting myeloid cell leukemia sequence 1.
  155. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting nucleoporin 62kDa (Nup62).
  156. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting polo-like kinase-1 (PLK-1).
  157. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting protein kinase N-3 (PKN-3).
  158. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting proto-oncogene MET.
  159. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting proto-oncogene MET.
  160. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2).
  161. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase).
  162. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase).
  163. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen, siRNA targeting spleen tyrosine kinase.
  164. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen; Read, Steven, siRNA targeting spleen tyrosine kinase.
  165. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting superoxide dismutase 1 (SOD1).
  166. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting superoxide dismutase 1 (SOD1).
  167. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen; Read, Steven, siRNA targeting survivin.
  168. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Scaringe, Stephen; Read, Steven, siRNA targeting survivin.
  169. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting tie-2.
  170. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting transducin (beta)-like 3 (TBL3).
  171. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting transient receptor potential cation channel, subfamily V, member 1 (TRPV1).
  172. Khvorova, Anastasia; Reynolds, Angela; Leake, Devin; Marshall, William; Read, Steven; Scaringe, Stephen, siRNA targeting tumor protein 53 (p53).
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로